Schedule 13G ownership disclosure

NEUROONE MED TECHNOLOGIES CO

Common stock, $0.001 par value · CUSIP: 64130M209

Event date: 2024-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 798,762.00 · Class: 2.5924%

  • Wilmot B. Harkey

    Shares: 798,762.00 · Class: 2.5950%

  • Daniel Mack

    Shares: 798,762.00 · Class: 2.5950%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-119159
Form type
SCHEDULE 13G/A
Filer
NEUROONE MEDICAL TECHNOLOGIES Corp
CIK
CIK 1500198
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub